This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Trump's US AI priorities highlight messy interplay of science, politics

By Emma Whitford ( April 11, 2025, 15:33 GMT | Comment) -- US President Donald Trump’s directive to expunge “ideological bias” from artificial intelligence has begun to reach government scientists and their public partners, raising questions about how Republican priorities could shape the way powerful AI systems are studied and evaluated within the National Institute of Standards and Technology. But while NIST has long guarded its reputation as an apolitical champion of scientific integrity, tensions over the messy interplay of science and politics are not new there. US President Donald Trump’s directive to expunge “ideological bias” from artificial intelligence has begun to reach government scientists and their public partners, raising questions about how Republican priorities could shape the way powerful AI systems are studied and evaluated within the National Institute of Standards and Technology....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections